The global market for microbial detection is expanding rapidly, driven by stringent regulatory standards in food safety, the push for sustainable agriculture, and escalating demands for infection control in healthcare. Traditional lab-based methods are often too slow and costly, creating a critical gap for on-site, real-time solutions. This technology offers a timely response to these market forces, enabling proactive risk management and operational efficiency across industries.
Enables on-site detection without specialized expertise, potentially reducing labor and training costs for skilled inspectors.
Achieves high-sensitivity detection in minutes by directly measuring microbial electron transfer function, eliminating the need for culture.
Secures market advantage with distinct technological superiority, evidenced by only two prior art documents, enabling early market share capture.
This patent protects a broad range of technical aspects, encompassing a measurement device and evaluation method for detecting biological particles with electron transfer functions using a biosensor with specific electrode configurations. The robust claims, established through successful responses to examiner objections, indicate strong defensibility against future invalidation challenges.
This patent primarily covers the core biosensor and detection method. White space exists for licensees to develop integrated IoT platforms for remote monitoring, advanced AI-driven predictive analytics for microbial trends, or novel automated sample preparation systems.
Eliminating the need for skilled inspectors could reduce personnel costs by ~$65K/year (AI est.). Additionally, rapid on-site detection may mitigate agricultural crop waste losses by ~$130K/year (AI est.).
X: Detection Speed and Accuracy
Y: Cost-Effectiveness and Ease of Operation